How Parkinson's patients experience a new injection treatment in real life

This study is following people with Parkinson's disease who have been prescribed ONAPGO, a new medication delivered through a continuous small infusion pump under the skin. Researchers want to understand how this treatment works in real life—how it helps patients feel and function day-to-day, and what their actual experience is like. The study will track participants from when they first start the medication through several months of regular use.

While this medication has been tested in clinical trials, researchers want to learn how it actually helps people manage their Parkinson's symptoms in their everyday lives, not just in a controlled research setting. This information will help doctors better understand who benefits most from the treatment and how to support patients using it.